Compare Moderna, Inc. (MRNA) vs AT&T Inc. (T) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs AT&T Inc. — how do they compare? Moderna, Inc. trades at $60.75 (market cap $24.18B), while AT&T Inc. trades at $24.4 (market cap $167.88B). The key difference: AT&T Inc. is far larger — about 6.9× Moderna, Inc.'s market cap, and AT&T Inc. pays a 4.53% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | T | |
|---|---|---|
Market Cap | $24.18B | $167.88B |
Sector | Health | Media |
52-Week High | $81.80 | $29.62 |
52-Week Low | $22.36 | $20.49 |
Enterprise Value | $20.33B | $313.20B |
Dividend Yield | — | 4.53% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About AT&T Inc.
AT&T Inc. is a communications holding company. The Company, through its subsidiaries and affiliates, provides local and long-distance phone service, wireless and data communications, Internet access and messaging, IP-based and satellite television, security services, telecommunications equipment, and directory advertising and publishing.
Read more on T →
